Physician profile
Michael Bergal
NPI 1174786420
$1,059.90
in general payments reported to CMS, 2019-2025
16 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.92 · 2020: $173 · 2021: $199 · 2022: $34.41 · 2023: $193 · 2024: $281 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.64 | 2021-2025 | Ubrelvy |
| Astrazeneca Pharmaceuticals Lp | $177.63 | 2020-2025 | Farxiga, Breztri |
| Pfizer INC. | $152.35 | 2020-2025 | |
| Radius Health, INC. | $57.98 | 2020-2024 | Tymlos |
| Takeda Pharmaceuticals U.S.A., INC. | $49.45 | 2020 | |
| Novo Nordisk INC | $48.44 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Exact Sciences Corporation | $47.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $44.61 | 2023-2025 | |
| Lilly USA, LLC | $41.67 | 2019-2024 | Jardiance, Zepbound |
| Amgen INC. | $26.63 | 2019-2020 | |
| Amarin Pharma, INC. | $23.83 | 2021 | |
| Ethicon US, LLC | $23.72 | 2021 | |
| Tactile Systems Technology INC | $16.06 | 2021 | |
| Edwards Lifesciences Corporation | $15.18 | 2023 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $14.52 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bergal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.